SOURCE: TraceLink Inc.

TraceLink Inc.

September 17, 2014 12:13 ET

TraceLink Supports New GS1 Healthcare US Guideline for DSCSA 2015 Compliance

Webinar to Review New GS1 EPCIS Standard and DSCSA Compliance Requirements Hosted by GS1 Standards Leaders

WAKEFIELD, MA--(Marketwired - Sep 17, 2014) -  TraceLink Inc., the leader in protecting patient safety and enabling health for global Life Sciences, announced today support for the just published GS1 Healthcare US Implementation Guideline v1.1 for Drug Supply Chain Security Act (DSCSA) compliance. TraceLink now offers the industry's first end-to-end DSCSA compliance solution supporting both lot-level and serialized product data exchange and serialization data management in a single cloud platform designed for Life Sciences.

GS1 EPCIS v1.1 joins HDMA ASN and secure web portals as standard DSCSA compliance data exchange options on the TraceLink Life Sciences Cloud network platform. Through a single connection to the platform, TraceLink ensures compliance with fast-approaching DSCSA January 2015 deadlines and future-proof support for 2017 and beyond DSCSA serialization and unit-level traceability requirements. TraceLink further reduces the burden of meeting complex DSCSA compliance requirements through our Network Services team which quickly connects all suppliers and trading partners into the Life Sciences Cloud for DSCSA compliance on behalf of our customers. The result: one connection, full DSCSA compliance across a company's supply network regardless of trading partner preferences or technical capabilities, no point-to-point network integration costs.

"TraceLink has deep experience and a track record of successful commercial deployments with GS1 EPCIS as evidenced by the work we've done with leading pharmaceutical companies and wholesale distributors in testing serialized product traceability for California ePedigree," said Shabbir Dahod, president and CEO of TraceLink. "Additionally TraceLink's VP Product Management, Lucy Deus has been a major contributor to the development of v1.1 in the GS1 Secure Supply Chain workgroup. Lucy has been a long-standing GS1 leader, including roles as technical editor of the Drug Pedigree Messaging Standard and being named 2007 EPCglobal Person of the Year."

Developed in 2009 and continuously evolved to meet the needs of the pharma supply chain, the TraceLink Life Sciences Cloud is the only secure cloud-based network platform designed for mission-critical Life Sciences operations. The Life Sciences Cloud provides a highly connected and agile network and supply chain control tower linking tens of thousands of pharmaceutical companies, CMO/CPOs, 3PLs, wholesalers and pharmacies.

TraceLink transforms the Life Sciences supply network. A single link to TraceLink's validated and audited platform provides complete connectivity to all suppliers and trading partners in a company's business network regardless of technical capabilities or data exchange preferences. The benefits:

  • End-to-end U.S. DSCSA compliance with a Transaction History Management System providing integrated tracing, verification and serialization capabilities with full lot-level and serialized product support.
  • End-to-end global track and trace compliance with native support for China, Korea, India, Brazil and other global serialization, traceability and reporting regulations on a single harmonized platform.
  • Improved external supply performance, enhanced outsourced manufacturing quality management and increased supplier transparency across global markets through a global supply network control tower.

Learn more about TraceLink's pharmaceutical track and trace solutions and supply network tower applications at

On October 8th at 1:00 pm ET join Lucy Deus, VP Product Management at TraceLink and Bob Celeste, Sr. Director, Pharmaceutical Sector Lead, GS1 US for an educational webinar reviewing the GS1 Guideline and discuss its use for DSCSA compliance. Visit for more information.

About TraceLink
TraceLink protects patients and enables health for companies across the global Life Sciences supply network through the TraceLink Life Sciences Cloud. The TraceLink Life Sciences Cloud is an Amazon AWS-based cloud application platform which enables complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. Winner of numerous industry awards including the Amazon AWS Global Start-Up Challenge Grand Prize and the Edison Award for Innovation in Health Management, the TraceLink Life Sciences Cloud is trusted by thirteen of the top-20 pharmaceutical companies and businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit or follow us on LinkedIn.

TraceLink is funded by FirstMark Capital. FirstMark Capital is an early stage venture capital firm based in New York City. FirstMark's mission is to partner with exceptional entrepreneurs who are changing the world by solving meaningful problems. FirstMark has built a deeply engaged community among the extraordinary teams in the FirstMark network to spread ideas and opportunities. FirstMark is privileged to work alongside the founders of remarkable businesses like Pinterest, Lumosity, Aereo, TapAd, Shopify, Riot Games, and dozens more. Visit FirstMark in New York City or online at and @FirstMarkCap.

Contact Information

  • Media contact:
    Joni Moore
    Red Javelin Communications
    Email Contact